FindTrial
Sign In

Effect of Psorogrit and Divya Taila in Subject suffering from Psoriasis

A Prospective, Open-Label, Single Arm, Observational Study on The Clinical Effectiveness of Psorogrit, and Divya Taila in the Management of Psoriasis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090404
Enrollment
45
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Patanjali Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PASI score more than 10 percent Participants who is willingly to participate and give written informed consent. Participants who are willing to undergo 3 months of treatment will be included.

Exclusion criteria

Exclusion criteria: Participants who are not willing to participate. Participants with a personal or family history of premalignant or malignant skin tumors. Pregnant lactating and planning for pregnancy. Participants with serious comorbid conditions like renal hepatic and severe cardiac disease.

Design outcomes

Primary

MeasureTime frame
The area and severity of psoriasis will be measured by using the Psoriasis Area and Severity Index score.Timepoint: At baseline and after Day 30 Day 60 and Day 90—

Secondary

MeasureTime frame
The quality of life of patients with psoriasis will be assessed by using the Dermatology Life Quality Index score.Timepoint: At baseline and after Day 30 Day 60 and Day 90—

Countries

India

Contacts

Public ContactDr Ajay Singh

Patanjali Ayurveda Hospital

drajaysingh82@gmail.com9039402300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026